Press Releases

Mar 22, 2022

PharmaCyte Biotech Successfully Completes 24-Month Stability Study of Its Clinical Trial Product Candidate

Mar 16, 2022

PharmaCyte Biotech Reports Third Quarter Financial Results and Operational Highlights

Feb 22, 2022

PharmaCyte Biotech Announces Genetic Stability of Cytochrome P450 Gene and Site of Integration

Feb 14, 2022

PharmaCyte Biotech Updates Status of Investigational New Drug Application to FDA

Jan 6, 2022

PharmaCyte Biotech to Present at H.C. Wainwright BioConnect Conference

Jan 4, 2022

PharmaCyte Biotech Study Proves Capsule Material Is Not Toxic For Encapsulated Cells

Dec 28, 2021

PharmaCyte Biotech Successfully Completes 36 Month Master Cell Bank Stability Study

Dec 15, 2021

PharmaCyte Biotech Reports Second Quarter 2021 Financial Results and Operational Highlights

Dec 8, 2021

PharmaCyte Biotech Successfully Completes Cytochrome P450 Site of Integration DNA Sequencing Assay

Nov 30, 2021

PharmaCyte Biotech Launches Malignant Ascites Program with Commencement of Pivotal Preclinical Study

« Previous
1
2
3
4
5
6
7
8
9
10
...29
Next »